Lilly 4Q Revenues: $6.1 billion (+8%) 4Q Earnings: $1.5 billion (+33%) FY Revenues: $22.3 billion (+4%) FY Earnings: $8.3 billion (up from $3.2 billion FY18) Comments: Key growth products launched since 2014, including Trulicity, Taltz, Jardiance, Verzenio, Olumiant, Emgality, Basaglar, and Cyramza, represented approximately 46% of total revenue.  Revenue in the U.S. increased 7% to $3.5 billion. Revenue outside the U.S. increased 10% to $2.6 billion. Trulicity sales were $1....